Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kentaro Bandobashi

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Immunology Letters|January 23, 2002
SH2D1A expression reflects activation of T and NK cells in cord blood lymphocytes infected with EBV and treated with the immunomodulator PSKAnquan Liu, George Klein, Kentaro Bandobashi, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|November 12, 2010
[A case of sarcoidosis following chemotherapy for follicular lymphoma]Mizu Sakai, Kentaro Bandobashi, Takayuki Ikezoe, et al.
Journal of Virology|April 14, 2005
Induction of lytic Epstein-Barr virus (EBV) infection by synergistic action of rituximab and dexamethasone renders EBV-positive lymphoma cells more susceptible to ganciclovir cytotoxicity in vitro and in vivoMasanori Daibata, Kentaro Bandobashi, Masayuki Kuroda, et al.
Molecular Cancer Therapeutics|April 14, 2004
HIV-1 protease inhibitor induces growth arrest and apoptosis of human multiple myeloma cells via inactivation of signal transducer and activator of transcription 3 and extracellular signal-regulated kinase 1/2Takayuki Ikezoe, Tsuyako Saito, Kentaro Bandobashi, et al.
Oncology Reports|March 8, 2007
Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on lung cancer: roles of cyclooxygenase-2Yoshiki Uemura, Makoto Kobayashi, Hideshi Nakata, et al.
International Journal of Molecular Medicine|July 6, 2006
Effects of GM-CSF and M-CSF on tumor progression of lung cancer: roles of MEK1/ERK and AKT/PKB pathwaysYoshiki Uemura, Makoto Kobayashi, Hideshi Nakata, et al.
International Journal of Molecular Medicine|October 8, 2005
Role of protein kinase C in expression of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cellsYoshiki Uemura, Makoto Kobayashi, Hideshi Nakata, et al.
Anticancer Research|April 20, 2006
Diffuse micronodular pulmonary metastasis of lung adenocarcinoma predicts gefitinib response in association with epidermal growth factor receptor mutationsMakoto Kobayashi, Tamotsu Takeuchi, Kentaro Bandobashi, et al.
Internal Medicine (Tokyo, Japan)|May 29, 2007
Idiopathic hypereosinophilic syndrome presenting acute abdomenMakoto Kobayashi, Naoki Komatsu, Yoshio Kuwayama, et al.
Medical Molecular Morphology|December 25, 2008
Ultrastructural study of the morphogenesis of human herpesvirus 6 type B in human T-lymphotropic virus type I-producing lymphoid cellsYuji Ohtsuki, Masanori Daibata, Kentaro Bandobashi, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Immunology Letters|January 23, 2002
SH2D1A expression reflects activation of T and NK cells in cord blood lymphocytes infected with EBV and treated with the immunomodulator PSKAnquan Liu, George Klein, Kentaro Bandobashi, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|November 12, 2010
[A case of sarcoidosis following chemotherapy for follicular lymphoma]Mizu Sakai, Kentaro Bandobashi, Takayuki Ikezoe, et al.
Journal of Virology|April 14, 2005
Induction of lytic Epstein-Barr virus (EBV) infection by synergistic action of rituximab and dexamethasone renders EBV-positive lymphoma cells more susceptible to ganciclovir cytotoxicity in vitro and in vivoMasanori Daibata, Kentaro Bandobashi, Masayuki Kuroda, et al.
Molecular Cancer Therapeutics|April 14, 2004
HIV-1 protease inhibitor induces growth arrest and apoptosis of human multiple myeloma cells via inactivation of signal transducer and activator of transcription 3 and extracellular signal-regulated kinase 1/2Takayuki Ikezoe, Tsuyako Saito, Kentaro Bandobashi, et al.
Oncology Reports|March 8, 2007
Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on lung cancer: roles of cyclooxygenase-2Yoshiki Uemura, Makoto Kobayashi, Hideshi Nakata, et al.
International Journal of Molecular Medicine|July 6, 2006
Effects of GM-CSF and M-CSF on tumor progression of lung cancer: roles of MEK1/ERK and AKT/PKB pathwaysYoshiki Uemura, Makoto Kobayashi, Hideshi Nakata, et al.
International Journal of Molecular Medicine|October 8, 2005
Role of protein kinase C in expression of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cellsYoshiki Uemura, Makoto Kobayashi, Hideshi Nakata, et al.
Anticancer Research|April 20, 2006
Diffuse micronodular pulmonary metastasis of lung adenocarcinoma predicts gefitinib response in association with epidermal growth factor receptor mutationsMakoto Kobayashi, Tamotsu Takeuchi, Kentaro Bandobashi, et al.
Internal Medicine (Tokyo, Japan)|May 29, 2007
Idiopathic hypereosinophilic syndrome presenting acute abdomenMakoto Kobayashi, Naoki Komatsu, Yoshio Kuwayama, et al.
Medical Molecular Morphology|December 25, 2008
Ultrastructural study of the morphogenesis of human herpesvirus 6 type B in human T-lymphotropic virus type I-producing lymphoid cellsYuji Ohtsuki, Masanori Daibata, Kentaro Bandobashi, et al.
Pageof 3